7FM0 Stock Chart & Stats
€0.06
€0.00(0.00%)
At close: 4:00 PM EDT
€0.06
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€0.05 - €0.53
Previous CloseN/A
Volume0.00
Average Volume (3M)1.54K
Market Cap
€3.06M
Enterprise Value€12.73
Total Cash (Recent Filing)€1.05M
Total Debt (Recent Filing)€12.93M
Price to Earnings (P/E)―
Beta21.43
Next Earnings
Aug 31, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.21
Shares Outstanding32,793,960
10 Day Avg. Volume420
30 Day Avg. Volume1,538
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)45.96
Price to Sales (P/S)534.40
P/FCF Ratio-3.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue ReappearedThe return of reported revenue provides initial evidence of commercial activity and product or service monetization. However, the very small base means this remains an early signal rather than proof of durable scale or recurring growth.
Gross MarginA 100% reported gross margin indicates that current revenue did not carry recorded direct costs, which could support attractive unit economics if revenue expands. Sustainability remains unproven because operating expenses and losses substantially exceed the revenue base.
Asset BaseThe reported asset base gives the company a substantive operating and financing foundation relative to its current revenue. Its usefulness is limited by heavy debt, thin equity, and continuing losses, but assets may still support future commercialization or restructuring efforts.
Bears Say
Persistent LossesOperating costs are vastly above the current revenue base, producing persistent and significant losses. Unless revenue scales dramatically or expenses are reduced, the cost structure will continue to require financing and will limit the credibility of a sustainable earnings model.
Negative Cash FlowConsistent cash consumption means the company has not demonstrated self-funding operations. Continued negative operating and free cash flow increases dependence on external capital, creating ongoing financing risk and potentially constraining investment in business development.
Extreme LeverageDebt greatly exceeds the thin equity base, while prior negative equity highlights limited financial resilience. This structure raises refinancing and dilution risk, leaves little cushion for operating setbacks, and may restrict the company’s ability to fund long-term growth.
Beyond Medical Technologies Inc News
7FM0 FAQ
What was Beyond Medical Technologies Inc’s price range in the past 12 months?
Beyond Medical Technologies Inc lowest stock price was €0.05 and its highest was €0.53 in the past 12 months.
What is Beyond Medical Technologies Inc’s market cap?
Beyond Medical Technologies Inc’s market cap is €3.06M.
When is Beyond Medical Technologies Inc’s upcoming earnings report date?
Beyond Medical Technologies Inc’s upcoming earnings report date is Aug 31, 2026 which is in 9 days.
How were Beyond Medical Technologies Inc’s earnings last quarter?
Currently, no data Available
Is Beyond Medical Technologies Inc overvalued?
According to Wall Street analysts Beyond Medical Technologies Inc’s price is currently Overvalued.
Does Beyond Medical Technologies Inc pay dividends?
Beyond Medical Technologies Inc does not currently pay dividends.
What is Beyond Medical Technologies Inc’s EPS estimate?
Beyond Medical Technologies Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Beyond Medical Technologies Inc have?
Beyond Medical Technologies Inc has 32,793,960 shares outstanding.
What happened to Beyond Medical Technologies Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Beyond Medical Technologies Inc?
Currently, no hedge funds are holding shares in DE:7FM0
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Beyond Medical Technologies Inc
Republic Technologies Inc. primarily focuses on the production of personal protective equipment (PPE). Its operations are strategically divided into three main divisions: Corporate, the PPE Sector, and Waste Treatment. Established by Bharath Bhushan on November 29, 2006, the company's headquarters are situated in Vancouver, Canada.